Blood-brain barrier penetration of cefepime after neurosurgery

被引:0
|
作者
WANG Jiang-fei WANG Qiang ZHAO Li-hong SHI Guang-zhi ZHOU Jian-xin Department of Neurosurgery ICU Beijing Tiantan Hospital
机构
关键词
cefepime; blood-brain barrier; drug concentration; high-pressure liquid chromatography;
D O I
暂无
中图分类号
R651 [头部及神经外科学]; R96 [药理学];
学科分类号
1002 ; 100210 ; 100602 ; 100706 ;
摘要
Background It has been confirmed that the concentration of cefepime in cerebrospinal fluid(CSF)could reach the 10%of its concentration in plasma,exceeding the inhibitory concentration to 90% of organisms(MIC9o)for common bacteria.However,the blood-brain barrier(BBB)penetration ability of cefepime is still unclear.The aim of this study was tomeasure the CSF concentration of cefepime in patients after neurosurgical operations,and to determine the penetrationof the drug through an incomplete BBB.Methods Eight patients who received ventricular drainage(VD group)and 5 who underwent lumbar puncture drainage(LPD group)were enrolled into this study.Cefepime(2 g)was injected intravenously in 30 minutes after theneurosurgeries.The concentrations of cefepime in the CSF and plasma were measured by high-pressure liquidchromatography(HPLC)at different time points.Results The CSF concentrations of cefepime at different time points in the VD group were significantly higher thanthose in the LPD group(P<0.05).In the VD group,the concentration of cefepime in CSF reached the peak((22.544.06)μg/ml)at 1 to 2 hours after the injection,while in the LPD group at 4 hours((5.61±3.73)μg/ml).In both groups,the peakwas higher than the MICof most common bacteria in intensive care unit.The ratio of CSF to plasma cefepimeconcentrations ranged from 0.30 to 2.14 in the VD group and 0.03 to 1.14 in the LPD group.Conclusion After neurosurgeries,CSF concentration of cefepime can reach a therapeutic level.Thus,the drug couldbe used to prevent and treat postoperative intracranial infection.Chin Med J 2007;120(13):1176-1178
引用
收藏
页码:1176 / 1178
页数:3
相关论文
共 50 条
  • [31] An in vitro Blood-brain Barrier Model to Study the Penetration of Nanoparticles
    Aday, Sezin
    Li, Wen
    Karp, Jeffrey M.
    Joshi, Nitin
    BIO-PROTOCOL, 2022, 12 (04):
  • [32] Penetration of solutes, viruses, and cells across the blood-brain barrier
    Brightman, MW
    Ishihara, S
    Chang, L
    HIV AND DEMENTIA, 1995, 202 : 63 - 78
  • [33] Cell-based models of blood-brain barrier penetration
    Vastag, Monika
    Hellinger, Eva
    Bakk, Monika L.
    Tihanyi, Karoly
    THERAPEUTIC DELIVERY, 2011, 2 (05) : 549 - 553
  • [34] Rapidly profiling blood-brain barrier penetration with liposome EKC
    Wang, Yongjun
    Sun, Jin
    Liu, Hongzhuo
    He, Zhonggui
    ELECTROPHORESIS, 2007, 28 (14) : 2391 - 2395
  • [35] A Bayesian Approach to in Silico Blood-Brain Barrier Penetration Modeling
    Martins, Ines Filipa
    Teixeira, Ana L.
    Pinheiro, Luis
    Falcao, Andre O.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2012, 52 (06) : 1686 - 1697
  • [36] Mini review on blood-brain barrier penetration of pyridinium aldoximes
    Kalasz, H.
    Nurulain, S. M.
    Veress, G.
    Antus, S.
    Darvas, F.
    Adeghate, E.
    Adem, A.
    Hashemi, F.
    Tekes, K.
    JOURNAL OF APPLIED TOXICOLOGY, 2015, 35 (02) : 116 - 123
  • [37] Predictive model of blood-brain barrier penetration of organic compounds
    Xiao-lei MA Cheng CHEN Jie YANG~2 State Key Laboratory of Pharmaceutical Biotechnology
    ActaPharmacologicaSinica, 2005, (04) : 500 - 512
  • [38] Prediction of blood-brain barrier penetration: are we missing the point?
    Martin, I
    DRUG DISCOVERY TODAY, 2004, 9 (04) : 161 - 162
  • [39] THE PREDICTION OF BLOOD-BRAIN BARRIER PENETRATION FOR MOLECULAR IMAGING AGENTS
    Newington, Ian M.
    Nairne, R. James D.
    Wynn, Duncan G.
    DRUGS OF THE FUTURE, 2009, 34 : 86 - 86
  • [40] CHANGES IN THE BLOOD-BRAIN BARRIER AFTER EXPOSURE OF THE BRAIN
    SAMORAJSKI, T
    MOODY, RA
    ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1957, 78 (OCT): : 369 - 376